RadNet

Intra-Cellular Therapies

Wave Life Sciences

Insmed

Blueprint Medicines

BridgeBio Pharma Inc

Livanova

Merit Medical Systems

NeoGenomics

Soleno Therapeutics

F/m Emerald Life Sciences Innovation ETF

LFSC is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities.

LANCASTER, Pa.--(BUSINESS WIRE)--Emerald Advisers, in partnership with F/m Investments, today announces the launch of the F/m Emerald Life Sciences Innovation ETF (LFSC), now trading on the Nasdaq Stock Market under the ticker LFSC. This ETF offers investors exposure to the most innovative companies in the life sciences sector, focusing on biotech, healthcare, and medical device advancements. “We are excited to bring this ETF to market, offering investors access to some of the most cutting-edge.

Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC)

News for F/m Emerald Life Sciences Innovation ETF ETF (LFSC)